Cancer treatment—residual (R) tumour indicator, yes/no code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type:![]() | Data Element |
---|---|
Short name:![]() | Residual tumour indicator |
METEOR identifier:![]() | 430267 |
Registration status:![]() |
|
Definition:![]() | An indicator of whether residual tumour is present after the course of treatment for cancer, as represented by a code. |
Data Element Concept:![]() | Cancer treatment—residual (R) tumour indicator |
Value domain attributes | |||||||
Representational attributes | |||||||
Representation class:![]() | Code | ||||||
---|---|---|---|---|---|---|---|
Data type:![]() | Boolean | ||||||
Format:![]() | N | ||||||
Maximum character length:![]() | 1 | ||||||
Permissible values:![]() |
| ||||||
Data element attributes | |||||||
Collection and usage attributes | |||||||
Guide for use:![]() | Record the presence of residual tumour on completion of the course of treatment for cancer. In some cases treated with surgery and/or neoadjuvant therapy, residual tumour will be present at the primary site after treatment because of incomplete resection or local and regional disease extending beyond the scope of resection. | ||||||
Collection methods:![]() | This information should be sought from the patient's medical record, referral letters or attending medical clinician. | ||||||
Comments:![]() | The presence of residual tumour may indicate the effect of treatment, influence further treatment decisions, and be a strong predictor of prognosis. | ||||||
Source and reference attributes | |||||||
Submitting organisation:![]() | Cancer Australia | ||||||
Reference documents:![]() | American Joint Committee on Cancer 2010. AJCC Cancer Staging Manual, 7th edition. Springer: New York | ||||||
Relational attributes | |||||||
Implementation in Data Set Specifications:![]() | Health, Superseded 14/05/2015 Conditional obligation: This data element is to be recorded for patients with ovarian cancer and stage IV endometrial cancer when surgical treatment for gynaecological cancer has been completed. Health, Standard 14/05/2015 Conditional obligation: This data element is to be recorded for patients with ovarian cancer and stage IV endometrial cancer when surgical treatment for gynaecological cancer has been completed. Health, Superseded 14/05/2015 Conditional obligation: Collect when a person with cancer has completed their initial course of cancer treatment. Health, Standard 14/05/2015 Conditional obligation: Collect when a person with cancer has completed their initial course of cancer treatment. |
<Title>
<body>
<footer>